Distinct phenotypes in COVID-19 may require distinct pulmonary rehabilitation strategies
Submitted: July 22, 2020
Accepted: November 4, 2020
Published: December 3, 2020
Accepted: November 4, 2020
Abstract Views: 1503
PDF: 878
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Gennaro Ratti, Cinzia Monda, Federica Ratti, Marco Golino, Ludovica Fulgione, Cosimo Fulgione, Mario Mallardo, Paolo Tammaro, Long-term dual antiplatelet therapy and nuisance bleeding: impact on quality of life , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Syed Muhammad Zubair, Muhammad Mustansir Mehdi Khan, Yasmin Rahim, Hamza Ahmed Ibad, Muhammad Irfan, Impact of immune status on the clinical characteristics, treatment outcomes and mortality of pulmonary nocardiosis: a retrospective analysis in a tertiary care hospital from a low- to middle-income country , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Pierluigi Carratù, Roberto Boffi, Silvano Dragonieri, Elena Munarini, Chiara Veronese, Piero Portincasa, Covid-19 and ex-smokers: an underestimated prognostic factor? , Monaldi Archives for Chest Disease: Vol. 90 No. 3 (2020)
- Moiz Salahuddin, Samia Ayub, Spontaneous large volume hemothorax managed with a small-bore chest tube , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Atefeh Mir, Khadijeh Kalan Farmanfarma, Hamid Salehiniya, Abolfazl Shakiba, Neda Mahdavifar, Laboratory and demographic findings among patients with coronavirus disease 2019: a review , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Vivek Sharma, Pruthu Thekkur, Poonam R. Naik, Brojo Kishore Saha, Niraj Agrawal, Milan K. Dinda, S. Parthiban, Abhijit Dey, Basavaraj Poojar, Amrita N. Shamanewadi, Srinath Satyanarayana, Treatment success rates among tuberculosis patients notified from the private sector in West Bengal, India , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Vidushi Rathi, Pranav Ish, Comments on “Clinical, radiological and histopathological profile of patients with endobronchial lesions on fibreoptic bronchoscopy” by Sarma et al. , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Anu Anna George, Tejveer Singh, Pradnya Brizmohan Bhattad, Akil A. Sherif, Ajay Kumar Mishra, Serratia endocarditis, uncommon organism, with significant complications , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Giorgio E. Polistina, Francesca Simioli, Pasquale Imitazione, Maurizia Lanza, Anna Annunziata, Giuseppe Fiorentino, Different presentation of pulmonary parenchymal disruption in COVID-19 pneumonia. Case series of Sub-Intensive Care Unit in Naples, Italy , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Nikhil Rajvanshi, Prawin Kumar, Jagdish Prasad Goyal, Utility of systemic immune-inflammation Index as a serum biomarker to differentiate between complicated and simple para-pneumonic effusion , Monaldi Archives for Chest Disease: Early Access
<< < 81 82 83 84 85 86 87 88 89 90 > >>
You may also start an advanced similarity search for this article.